|Bid||119.01 x 800|
|Ask||120.29 x 900|
|Day's range||118.65 - 121.69|
|52-week range||90.73 - 172.65|
|Beta (5Y monthly)||1.05|
|PE ratio (TTM)||86.55|
|Earnings date||29 Jan 2024|
|Forward dividend & yield||5.08 (4.17%)|
|Ex-dividend date||28 Dec 2023|
|1y target est||131.58|
High demand for Alexandria's (ARE) top-quality life science assets bodes well. Yet, a vast development outlay exposes it to the risk of rising construction costs amid high-interest rates.
In the realm of real estate investment trusts (REITs), insider transactions are closely monitored by investors seeking clues about a company's financial health and future prospects.
Investors may keep a tab on stocks like ARE, SUZ, GGG, COFS and LZB, which have lately hiked their dividend payments.